Office of the VP for Communications – Keeping alumni and friends connected to U-M

Research News

  1. ‘Holy grail’ battery doubles the range of electric vehicles

    Lithium metal batteries can double the capacity of today’s standard lithium-ion cells, and much of the existing manufacturing system is primed for production, say experts at U-M. Let’s roll!

  2. Hurricanes, hospitals, and health care

    As extreme weather events multiply, U-M researchers have found a troubling lack of primary care doctors, surgeons, and specialists in some of the hardest-hit communities.

  3. Is the end in sight?

    Get an inside look at the COVID-19 vaccine development and approval process with U-M Professor of Epidemiology Arnold Monto. He is the acting chair of the FDA’s Vaccines and Related Biological Products and Advisory Committee.

  4. Michigan Medicine vaccinates first employees for COVID-19

    Michigan Medicine began vaccinating people against COVID-19 Dec. 14 with an initial group of five frontline workers.

  5. Interest surges in ad-free, censorship-free social sites

    Since November 3, people have been flocking to social media platforms Parler and MeWe, which promise ad-free or uncensored experiences.

  6. Life after COVID-19 hospitalization

    Study shows death, rehospitalization, and problems with basic activities, jobs, mental health, and finances plague many coronavirus patients.

  7. How to keep COVID-19 from invading your ‘pod’

    Michigan Medicine suggests what to do if someone in your learning group, friend group, or social circle gets exposed to or becomes sick with coronavirus.

  8. A new weapon against HIV

    Researchers have discovered an antibiotic molecule that enables the immune system to kill HIV-infected cells. Now the quest begins to optimize the compound and move closer to a viable therapy.

  9. Promising new test could advance Alzheimer’s treatment

    A new blood test may detect this harrowing disease before symptoms appear, which would offer an affordable alternative to the brain imaging and behavioral tests that often fail to identify Alzheimer’s in its earliest stages.